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DObjectives:About 1 in 5 patients with renal cell carcinoma have intravascular tumoral extension at presentation.
Level of tumoral extension within inferior vena cava determines surgical approach, with higher extension requir-
ing cardiopulmonary bypass. Tumoral invasion of inferior vena caval wall is associated with poor prognosis. We
evaluated accuracy of magnetic resonance imaging (MRI) in assessing level of intravascular extension of renal
cell carcinoma and predicting vessel wall invasion.
Methods:MRIs and surgical database were reviewed from January 1999 to December 2008. Sixty-four patients
with suspected intravascular extension of renal cell carcinoma underwent MRI. Forty-one underwent curative or
palliative surgery at our institution and were included in final analysis. MRI scans were reviewed to determine
intravascular extension and tumoral adherence to the vessel wall, as assessed by circumferential flow around the
intravascular tumor and its mobility during different phases of cardiac cycle. MRI findings were correlated with
surgical findings to assess accuracy.
Results: There was 87.8% agreement (P<.001; k ¼ 0.82) between MRI and surgical findings regarding level
of intravascular extension of tumor. MRI was highly sensitive and specific (93%) in assessing supradiaphrag-
matic extension (negative predictive value, 96%). Depending on sign used, sensitivities and negative predic-
tive values in assessing tumoral adherence to vessel wall ranged from 86% to 95% and 81% to 91%,
respectively.
Conclusions:MRI is highly accurate in staging intravascular and intracardiac extension, aiding in accurate pre-
operative surgical planning. MRI may help determine prognosis of renal cell carcinoma by accurately assessing
tumoral adherence to the vessel wall. (J Thorac Cardiovasc Surg 2012;144:845-51)Renal cell carcinoma (RCC) accounts for 3% to 4% of can-
cers in the United States,1 and its worldwide incidence and
mortality are increasing at 2% to 3% per decade.2 At pre-
sentation, venous extension is reported to occur in 20% of
patients. The inferior vena cava (IVC) is involved in as
many as 15% of all patients with RCC, and right atrial in-
volvement is seen in approximately 1% of cases.3-6
Surgical management is preferred, because RCC is uni-
formly resistant to chemotherapy and not sensitive enough
to radiotherapy.7-9 Intravascular tumoral extension is
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The Journal of Thoracic and Caa complete resection is possible.6,10 Extension into the
IVC, however, is associated with a poorer survival
outcome than is extension into the renal vein.11 The level
of tumoral extension within the IVC determines the surgical
approach used, with supradiaphragmatic extension requir-
ing cardiopulmonary bypass (CPB) with or without deep
hypothermic circulatory arrest.12,13 It is thus vital to
determine the level of intravascular tumoral extension
preoperatively. This not only facilitates surgical planning
but also allows appropriate involvement of cardiac
surgical teams.
Significant difference in prognosis exists between
patients with tumoral invasion of the IVC wall and those
with free-floating tumor in the IVC.14,15 Hatcher and
colleagues14,16 reported the 5-year survivals in the 2 groups
to be 25% and 69%, respectively. Direct tumoral invasion
of IVC wall, into surrounding soft tissue, can be determined
by multidetector computed tomography (MDCT) or
magnetic resonance imaging (MRI; Figure 1).17,18
Recognition of vessel wall invasion at early stages, when
tumor is adherent to the vessel wall, can be difficult to
assess by any imaging modality.
In this study, we looked at the accuracy of cardiovascular
MRI in assessing the level of intravascular tumoral exten-
sion of RCC and the ability of MRI to predict vessel wall
invasion.rdiovascular Surgery c Volume 144, Number 4 845
FIGURE 1. Half-Fourier acquisition single-shot turbo spin echo axial im-
age of upper abdomen showing right renal cell carcinoma (star)with exten-
sive peritoneal soft tissue extension (arrows).
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
IVC ¼ inferior vena cava
MDCT ¼ multidetector computed tomography
MRI ¼ magnetic resonance imaging
NPV ¼ negative predictive value
RCC ¼ renal cell carcinoma
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DMATERIALS AND METHODS
Patients
Cardiovascular MRIs and the surgical database of a single tertiary car-
diothoracic referral center (Royal Brompton and Harefield Foundation
Trust) were reviewed between January 1999 and December 2008. All pa-
tients who underwent MRI for assessment of known RCC with suspected
vascular extension were included in the study. Demographic data, intrao-
perative findings, and pathology reports were collated. Patients who under-
went curative or palliative surgery at our institution were included in the
final analysis. Patient consent was not deemed to be necessary by the local
research and ethics committee.
MRI Scan Protocols
During the period of study, all the scans were performed in 1 of our 3
1.5-T systems (2 Avanto and 1 Sonata; Siemens Medical Systems, Erlan-
gen, Germany). Standard scan protocol included (Table 1) the following:
half-Fourier acquisition single-shot turbo spin echo and cinematic
steady-state free precession sequences of the heart in standard cardiac
planes (2-, 3-, and 4-chamber and short-axis views) to establish cardiac
anatomy and function. Half-Fourier acquisition single-shot turbo spin
echo and single-shot steady-state free precession images of the abdomen
and pelvis (axial and coronal planes) were acquired to assess anatomy
and extent of local and vascular tumoral invasion. A stack of cinematic
steady-state free precession images covering the IVC was acquired in 2
planes to assess tumoral invasion of the vessel wall. Gadolinium-
enhanced renal angiography in arterial and venous phases was used to de-
tect level of vascular invasion and wall invasion. Toward the latter half of
the study, volumetric interpolated breath-hold examination sequence of the
abdomen was performed after angiography (Figure 2).
MRI Data Analysis
MRI images were reviewed, independent of the surgical findings, by 2
authors (V.R. and F.A.) with 5 ormore years of experience in cardiovascular
MRI. Consensus opinion was used for statistical analysis. Specific analysis
was made regarding the level of intravascular tumoral extension by stratify-
ing patients into 4 groups according to the level of intravascular extension
per the classification proposed by Neves and Zincke19 (Figure 3): involve-
ment of the renal vein (level I), involvement of the infrahepatic IVC (level
II), involvement of the intrahepatic IVC (level III), and supradiaphragmatic
extension (level IV). To assess tumoral adherence to the vessel wall, 2 spe-
cific MRI signs were analyzed. First sign looked at circumferential blood
flow around the intravascular tumor component on true fast imaging with
steady-state precession and postcontrast images (Figure 4). Second sign
looked at the mobility of the intravascular extension on cinematic images
during different phases of the cardiac cycle. Tumorwas considered to be ad-
herent to the vessel wall if there was no circumferential flow around it, if it
was not mobile within the vessel, or both.
Statistical Analysis
Statistical analysis was performed with Stata software (version 10; Sta-
taCorp LP, College Station, Tex). MRI staging of intravascular extension846 The Journal of Thoracic and Cardiovascular Surgwas compared with intraoperative staging to assess agreement by means
of k statistics. The accuracy of MRI in predicting the level of intravascular
extension was calculated by assessing sensitivity and specificity values for
individual stages, with the surgical findings considered the criterion stan-
dard. The MRI findings of circumferential flow and tumoral mobility
were specifically analyzed against the intraoperative finding of tumoral ad-
herence to the vessel wall. The sensitivity and specificity ofMRI in predict-
ing the need for CPB (levels III and IV) were also assessed.RESULTS
Study Population
A total of 64 patients with RCC underwent MRI as part of
the staging process during the period of study. There were
34 men and 30 women with a median age of 62 years,
(range, 24–83 years). Forty-three patients had right kidney
tumors, 19 had left-sided tumors, and 2 patients had bilat-
eral RCC. MRI scan was generally well tolerated by
patients, with only a couple of incidents in which subopti-
mal images were obtained because patients were unable
to breath hold. On average, the scan duration was less
than an hour, and delayed myocardial enhancement imag-
ing after gadolinium contrast was performed in patients
with known or suspected coronary artery disease.Surgical Management
Of the 64 patients, 10 were not suitable candidates for
radical or palliative surgery in view of their comorbidities
or metastatic spread of the disease. These patients were
referred to the oncologists or a palliative care team and
were excluded from this analysis. Twelve patients were
referred back to their primary hospitals for further man-
agement and were excluded from the analysis because op-
erative details were not available. One patient underwent
exploratory laparotomy and was excluded from this anal-
ysis. In total, 41 patients who underwent curative or pal-
liative surgery at our institution were included for
statistical analysis. Average time lag between the MRIery c October 2012
TABLE 1. Magnetic resonance imaging protocol
HASTE SSFP SS SSFP cine CE-MRA VIBE
TR/TE 700/42 292.1/1.22 40.2/1.13 2.85/1.19 5.73/2.64
Flip angle 160 80 80 15 10
Field of view
Read (mm) 340 340 320 350 350
Phase (%) 75 81.3 68.8 75 75
Acquisition
Base resolution 256 256 192 384 256
Phase resolution (%) 59 65 100 80 70
Slice resolution (%) — — — 79 64
Slices per slab — — — 96 64
Slice thickness (mm) 6 6 7 1.3 2.5
Phases per cardiac cycle — — 25 — —
Bandwidth (Hz/pixel) 781 888 930 690 250
iPAT GRAPPA 32 GRAPPA 32 — GRAPPA 32 GRAPPA 32
HASTE, Half-Fourier acquisition single-shot turbo spin echo; SSFP, steady-state free precession; SS, single shot; cine, cinematic; CE-MRA, contrast-enhanced magnetic
resonance angiogram; VIBE, volumetric interpolated breath-hold examination; TR, repetition time; TE, echo time; iPAT, integrated parallel acquisition techniques; GRAPPA,
generalized autocalibrating partially parallel acquisition.
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Time lag was less than 30 days for 25 patients and
more than 60 days for 4 patients. Three patients, 2 under-
going palliative surgery and 1 with level II extension, did
not require CPB.FIGURE 2. Different sequences in axial plane used for assessing a patient wit
Fourier acquisition single-shot turbo spin echo; B, steady-state free precession
D, Volumetric interpolated breath-hold examination image shows left renal cel
The Journal of Thoracic and CaMRI Versus Surgical Findings
The MRI and surgically determined levels of intravascu-
lar tumoral thrombus extension are compared in Table 2.
There was 87.8% (P<.001; k ¼ 0.82) agreement between
MRI and intraoperative findings in assessing the level ofh left renal cell carcinoma with suspected intravascular extension. A, Half-
; C, postcontrast. Images show the right atrial extension of tumor (arrow).
l carcinoma (star) with inferior vena caval tumoral thrombus (arrow).
rdiovascular Surgery c Volume 144, Number 4 847
FIGURE 3. Steady-state free precession static images in coronal plane depicting different levels of intravascular tumoral extension. A, Level I, renal vein
extension (black arrow) of right renal cell carcinoma (star). Also note left polycystic kidney (white arrow). B, Level II, infrahepatic inferior vena caval
extension (arrow) of right renal cell carcinoma. C, Level III, hepatic inferior vena caval extension (arrow) of the right renal cell carcinoma (star). D, Level
IV, supradiaphragmatic extension (arrow) into the right atrium.
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ities, and negative predictive values (NPVs) of MRI in de-
termining different levels of intravascular extension are
shown in Table 3. MRI was best in predicting level IVexten-
sion, with sensitivity and specificity of 93% and NPV of
96%. Specific analysis was made of levels III and IV to-
gether, because both these levels necessitate cardiac surgi-
cal team involvement during nephrectomy. All patients
with level IVextension onMRI required right atrial excision
for tumor removal, apart from 1 patient who underwent pal-
liative surgery for the abdominal disease. The sensitivities,
specificities, and NPVs of the 2 MRI signs in assessingFIGURE 4. Axial steady-state free precession images of 2 patients with level IV
white arrow) and no flow around the lesion on right (B, black arrow).
848 The Journal of Thoracic and Cardiovascular Surgtumoral adhesion to the vessel wall are shown in Table 4.
Both signs were accurate in predicting tumoral adherence
to the IVC wall (P<.001). Mobility of intravascular exten-
sion on MRI had a higher NPV (92%) in assessing tumoral
adherence to the vessel wall.
Of the 12 patients referred back to the primary hospital, 1
had no vascular extension, 2 had level I extension, and 9 had
tumor extending into infrahepatic IVC (level II). Four pa-
tients who had medical management had distant metastases
(1 level 0, 2 level II, and 1 level IV), 2 were not amenable to
surgery (1 level II and 1 level IV), and 4 were not thought to
bemedically fit to undergo surgery (3 level II and 1 level IV).disease. Note circumferential flow around tumoral extension on the left (A,
ery c October 2012
TABLE 2. Level of intravascular tumoral thrombus extension on
magnetic resonance imaging versus level determined at surgery
MRI
Surgery
I II III IV
I 1 0 0 0
II 0 13 1 0
III 0 1 9 1
IV 0 0 2 13
MRI, Magnetic resonance imaging.
TABLE 4. Sensitivities, specificities, and negative predictive values of
different magnetic resonance imaging observations in assessing
tumoral adherence to the vessel wall
Observation Sensitivity Specificity NPV
Circumferential flow around
intravascular extension
86% 65% 81%
Mobility of intravascular
extension
95% 55% 91%
NPV, Negative predictive value.
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Two of our patients were incidentally found to have car-
diac disease (left ventricular aneurysm and aortic stenosis).
The patient with aortic stenosis underwent a simple ne-
phrectomy and is under close surgical review for potential
aortic valve replacement. Ventricular aneurysm in the other
patient was secondary to previous myocardial infarction,
and this patient had undergone coronary artery bypass graft-
ing. Nonsurgical management was deemed appropriate af-
ter discussion with the patient. MRI also demonstrated
soft tissue, visceral, and bonymetastases in 15 patients, pre-
cluding them from curative surgery. Seven patients had
thrombus in the pulmonary arteries, and 1 had a segmental
liver infarct as a result of tumoral extension into the IVC
(Figure 5).DISCUSSION
Surgical resection is the only effective treatment for
RCC.20,21 Accurate preoperative staging of RCC is vital,
because the surgical approach to tumor resection varies
according to the level of intravascular tumoral extension.
Different imaging modalities, including MDCT, MRI, and
transesophageal echocardiography, are currently used to
determine intravascular tumoral extension. There is
limited published evidence regarding the accuracy of
these imaging modalities relative to intraoperative
findings. To the best of our knowledge, this is the largest
single-center study looking at the accuracy of cardiovascu-
lar MRI in assessing the intravascular tumoral extension
and its role in providing prognostic information in patients
with RCC.
There was significant agreement between the MRI-
determined vascular extension and the intraoperative find-
ings (87.8%; P < .001). The sensitivities, specificities,
and NPVs of MRI were different for different levels ofTABLE 3. Sensitivities, specificities, and negative predictive values of
magnetic resonance imaging for various levels of extension
Predicted level of extension Sensitivity Specificity NPV
IV 93% 93% 96%
III 75% 93% 90%
>II 96% 93% 93%
NPV, Negative predictive value.
The Journal of Thoracic and Caextension, with level IV assessment by MRI being the
best (NPV, 96%; sensitivity and specificity, 93%). Level
III and IV extensions usually warrant the involvement of
cardiac surgical teams, because CPB with or without deep
hypothermic cardiac arrest is required for adequate resec-
tion and hemostasis. MRI was highly sensitive (96%) and
specific (93%) and had a good NPV (93%) in predicting
level III or IV extension, thereby indicating the need of
CPB. Findings of our study are superior to previously re-
ported MRI sensitivities of 80% to 85%.22,23
MRI was inaccurate in staging intravascular extension in
5 patients. One patient had understaging of the disease as
level II (surgical level III) and 1 as level III (surgical level
IV). No specific reason for this understaging is apparent.
One plausible cause is rapid tumor growth between imaging
and surgery; however, the time lags between imaging and
surgery were not significant (27 and 33 days). Two patients
had overstaging of disease as level IV (time lags, 7 and 8
days) and 1 as level III (time lag, 89 days). In all 5 cases,
complete surgical excision was possible and did not require
any significant change in operative management.
The presence and extent of tumoral thrombus in the IVC
have limited influence on the prognosis, even when the
thrombus extends to the right atrium; however, significant
difference in prognosis exists between patients with tumoral
invasion of the IVC wall and those with free-floating tu-
moral thrombus in the IVC.14-16 Assessment of IVC wall
invasion by tumoral thrombus is thus an important part of
any staging investigation. Although MDCT is the most
widely used imaging technique for diagnosis and staging
of RCC, it can be unreliable in assessing direct invasion
of IVC wall by tumoral thrombus.4 The 2 MRI signs ana-
lyzed in this study were able to predict tumoral adherence
to the IVC wall accurately (P< .001). This information
not only will help in better surgical planning but also will
allow improved prognostication before surgery.
In our routine practice, patients with suspected RCC un-
dergoMDCTexamination at the outset. Cardiac MRI is per-
formed in patients with suspected level II or greater vascular
extension. Patients with suspected level III or IV extension
are also assessed perioperatively with transesophageal
echocardiography to ascertain supradiaphragmatic exten-
sion of tumor. The operative team includes an urologist,
a cardiothoracic surgeon, and an anesthesiologist. In thisrdiovascular Surgery c Volume 144, Number 4 849
FIGURE 5. Coronal images showing extracardiac pathologies detected on cardiac magnetic resonance imaging. A, Thrombus in right pulmonary artery
(arrow). B, Level IV tumor (arrow) with mediastinal lymph nodes (star). C, Liver infarct (arrow) secondary to left renal cell carcinoma (star). D, Multiple
lung metastases (arrow).
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of assessing the cardiac functional status, especially for
those people who will be undergoing CPB.
We do not suggest the use of cardiovascularMRI as a rou-
tine imaging examination for staging RCC. Instead, it
should be used as an adjuvant modality in patients who
have suspected or known vascular invasion and are under
consideration for surgery. The main reason for this is the
limited availability of technology and radiologic expertise
in the field of cardiovascular MRI. On the other hand,
MDCT is widely available and remains the ideal method
for assessing distant metastases.3 Assessment of supra-
diaphragmatic and right atrial extension on MDCT,
however, may require venous phase imaging with electro-
cardiographic gating. This will require cardiothoracic850 The Journal of Thoracic and Cardiovascular Surgexpertise and appropriate MDCT equipment, which may
not be universally available.
We do recognize the limitations of our study. Similar to
other studies on this subject,10 our study subjects comprised
a highly selected patient population, with most of the pa-
tients having previously diagnosed or suspected intravascu-
lar extension and being referred for surgical assessment.
This also accounts for a high incidence of CPB in our group.
Some of the patients with level I or II disease also required
CPB for excision of pulmonary tumoral emboli and bulky
IVC involvement. The retrospective nature of the study
may have led, as a result of the heterogeneity in imaging
techniques, parameters, and coil types, to underestimation
of the true performance of MRI. Images and reports from
other modalities were not routinely available; performanceery c October 2012
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adherence therefore could not be compared with MDCT
or echocardiography. The true prognostic value of cardiac
MRI–predicted tumoral adhesion and early invasion of the
vessel wall was not specifically assessed in this study. The
study was aimed at ascertaining the performance of MRI,
and therefore no mortality or morbidity data were collected.
Because of the lack of a control group (patients with RCC
not undergoing MRI), it is not possible to assess the influ-
ence of MRI on the outcomes of these patients.
In summary, accurate preoperative staging of RCC is
vital as surgical approach, and involvement of the cardiac
surgical team will vary depending on the tumoral extension.
MRI is highly accurate in staging intravascular and intracar-
diac extension. MRI may help in determining the prognosis
of patients with RCC by accurately assessing tumoral ad-
herence to the vessel wall.
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